The views of health guideline developers on the use of automation in health evidence synthesis
Open accessPublished version of a preprint
The DOI matches its Crossref record; 16 of the 16 references it cites were found in a registry or an index; 3 of the 19 sources its claims cite were checked for support.
Abstract
Background: The increasingly rapid rate of evidence publication has made it difficult for evidence synthesis—systematic reviews and health guidelines—to be continually kept up to date. One proposed solution for this is the use of automation in health evidence synthesis. Guideline developers are key gatekeepers in the acceptance and use of evidence, and therefore, their opinions on the potential use of automation are crucial. Methods: The objective of this study was to analyze the attitudes of guideline developers towards the use of automation in health evidence synthesis. The Diffusion of Innovations framework was chosen as an initial analytical framework because it encapsulates some of the core issues which are thought to affect the adoption of new innovations in practice. This well-established theory posits five dimensions which affect the adoption of novel technologies: Relative Advantage , Compatibility , Complexity , Trialability , and Observability . Eighteen interviews were conducted with individuals who were currently working, or had previously worked, in guideline development. After transcription, a multiphase mixed deductive and grounded approach was used to analyze the data. First, transcripts were coded with a deductive approach using Rogers’ Diffusion of Innovation as the top-level themes. Second, sub-themes within the framework were identified using a grounded approach. Results: Participants were consistently most concerned with the extent to which an innovation is in line with current values and practices (i.e., Compatibility in the Diffusion of Innovations framework). Participants were also concerned with Relative Advantage and Observability , which were discussed in approximately equal amounts. For the latter, participants expressed a desire for transparency in the methodology of automation software. Participants were noticeably less interested in Complexity and Trialability , which were discussed infrequently. These results were reasonably consistent across all participants. Conclusions: If machine learning and other automation technologies are to be used more widely and to their full potential in systematic reviews and guideline development, it is crucial to ensure new technologies are in line with current values and practice. It will also be important to maximize the transparency of the methods of these technologies to address the concerns of guideline developers.
Overview
CoChat Summary
TL;DR
This qualitative interview study analyzed guideline developers’ attitudes toward automation in health evidence synthesis using Rogers’ Diffusion of Innovations framework. Compatibility with professional values was the dominant concern, followed by Relative Advantage and Observability, while Complexity and Trialability were discussed least.
Key findings
- Across 18 interviews, Compatibility was the most prominently discussed theme; Relative Advantage and Observability were discussed in approximately equal amounts, and Complexity and Trialability were discussed infrequently.
- Within Compatibility, participants emphasized the ability to double-check automation output with human input and transparency as accountability, including freely accessible and examinable automation methods.
- Relative Advantage centered on freeing up human resources, with less emphasis on time and cost saving; no participants indicated openness to any trade-off between accuracy and time.
- Observability involved a need for rigorous evidence before adoption and ongoing ability to check machine-learning processes; contextual themes included low participant familiarity with automation and overall skepticism toward machine learning.
Methods
- Semi-structured one-on-one interviews were conducted via phone or Skype with 18 individuals currently or previously working in guideline development; 20 responded, and 2 were ineligible due to lack of firsthand guideline development experience.
- Participants were purposively sampled through personal and professional networks, including Guidelines International Network, NICE, and NHMRC.
- Transcripts were verbatim transcribed, participant-validated, and analyzed in QSR NVivo 12 using a thematic approach adapted for deductive and inductive analysis: Rogers’ Diffusion of Innovations provided top-level themes, followed by grounded open coding, theme generation, matrices, and identification of patterns and outliers.
Limitations
- The paper states that purposive sampling resulted in 18 participants from a relatively small number of organizations, with possible bias toward similar respondents; the sample was 28% male and over-represented Australian professionals (11 Australia, 7 USA/UK), though the authors note consistency in data suggested additional data might not change results.
- The paper states that the field appears to be in very early stages of broader adoption (innovators), so later studies may return different results; participants often reported feeling inexperienced with automation.
- Evident from the text: the study relies on self-reported views and does not directly test automation tools or observe guideline development workflows.
Model-written summary. Check it against the paper before relying on it.
Integrity signals
Registry
Cites
Statistics
Figures
Verification
Claims the paper makes
2 Valid · 0 Not valid · 12 Not checked · 73 Own results and interpretations
Every source the paper cites for this claim was checked and supports it.
In the paper
“As guidelines increasingly incorporate an evidence-based medicine approach, the systematic reviews which are a crucial component of this evidence have become overwhelmed by the rate of publication of new evidence [1].”
- Also stated in: § Background · plain
“The increasingly rapid rate of evidence publication has made it difficult for evidence synthesis—systematic reviews and health guidelines—to be continually kept up to date.”
§ The views of health guideline developers on the use of automation in health evidence synthesis > Background > Evidence-based guidelines are overwhelmed by the rate of research publication
What the sources say
- Supportedcites [1] Bastian H, Glasziou P, Chalmers I. Seventy-five trials and eleven systematic reviews a day: how will we ever keep up? PLoS Med. 2010;7(9):e1000326. source
The 'Where to Now?' section states that with 75 trials and 11 systematic reviews published daily and 'no signs of this slowing down', 'it would be just as hard to keep up with the systematic reviews', and that 'the increasing burdens placed on the methods of systematic reviewing could make the goal of keeping up-to-date with the knowledge won from trials recede ever more quickly'. The 'How Close Are We to Archie Cochrane's Goal?' section adds that 'the bulk of systematic reviews are now many years out of date', and 'Where to Now?' notes Cochrane 'has not been able to keep even half of its reviews up-to-date... and other organisations are in a similar predicament', with the KEEP Up collaboration explicitly involving guidelines bodies (SIGN, NICE, IQWiG) to harmonise updating. This covers the attributed point — the publication rate makes continual updating of systematic reviews and guidelines difficult; the framing clause about guidelines adopting evidence-based medicine is the citing authors' own context. (LLM, conf=0.88)
plainstates a cause- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
- Also stated in: § Background · plain
None of the sources cited for this claim have been checked yet.
In the paper
“There has not yet been significant primary research into barriers and facilitators to uptake of automation in health evidence synthesis contexts [7, 8].”
§ The views of health guideline developers on the use of automation in health evidence synthesis > Background > Limited literature addresses adoption of automation
What the sources say
- Not checked yetcites [7] van Altena AJ, Spijker R, Olabarriaga SD. Usage of automation tools in systematic reviews. Res Synthesis Methods. 2019;10(1):72–82. source
- Could not verifycites [8] Cleo G, et al. Usability and acceptability of four systematic review automation software packages: a mixed method design. Syst Rev. 2019;8(1):145. sourceExperimental — accuracy not yet measured
Our copy of Cleo et al. (2019) is a small qualitative usability study (n = 3 reviewers, 882 citations screened) and nowhere characterises the volume or absence of prior primary research on barriers and facilitators to uptake of automation. The Background (p. 1) only notes that 'despite advancements in automation of some of the steps of systematic reviews [1, 2], conducting a systematic review remains a largely manual process', and the Discussion concedes its own findings are provisional ('This can only be formally measured with a larger sample in future research') — statements about the technology and about this study's sample, not about the research landscape. Searches for 'no previous study / gap in the literature / limited research', 'barriers facilitators adoption take-up', and 'uptake of automation systematic reviews' returned no passage addressing the claim's point, so the attribution can be neither confirmed nor contradicted from our copy. (LLM, conf=0.60)
plain- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
A result the paper reports from its own data — it cites no other source for it, so there is none to check. The quote shows it is in the paper.
In the paper
“When prompted to discuss ML directly (in contrast to general views of evidence synthesis and guideline development approaches), participants tended to more frequently discuss ideas relating to the Relative Advantage of automation.”
§ The views of health guideline developers on the use of automation in health evidence synthesis > Results > Relative Advantage
plainstates an association- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: unclear — It is unclear whether the paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
A result the paper reports from its own data — it cites no other source for it, so there is none to check. The quote shows it is in the paper.
In the paper
“Most participants indicated the importance of the ability to double-check the output of automation with human researcher input.”
§ The views of health guideline developers on the use of automation in health evidence synthesis > Results > Ability to double-check
hedged- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
A result the paper reports from its own data — it cites no other source for it, so there is none to check. The quote shows it is in the paper.
In the paper
“When discussing Relative Advantage, participants focused on the freeing up of human resources, and to a lesser extent on time and cost saving.”
§ The views of health guideline developers on the use of automation in health evidence synthesis > Results > Relative Advantage
plain- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: unclear — It is unclear whether the paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
24 more claims
Create a free account to see all 87 claims and to verify the 16 references still open.
- Probably not a substantial claim. 46
- It may state two separate claims as one. 27
- The quote only partly states this claim. 3
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The cited source says what the claim attributes to it.
In the citing paper
“Arno et al.’s research [21] suggests that acceptance of ML within evidence synthesis is highly influenced by perceived methodological rigor.”
From Automating risk of bias assessment in systematic reviews: a real-time mixed methods comparison of human researchers to a machine learning system (2022) · cites this paper as [21]
In the citing paper
“The most cutting-edge and complex ML systems are often the least user-friendly and transparent, and both characteristics undermine uptake of ML in evidence synthesis 13 as well as more broadly.36”
From Machine learning in systematic reviews: Comparing automated text clustering with Lingo3G and human researcher categorization in a rapid review (2022) · cites this paper as [13]
Citations
Cites
Gale, N. K., Heath, G., Cameron, E., Rashid, S., & Redwood, S. (2013) · BMC Medical Research Methodology · doi:10.1186/1471-2288-13-117 · Cited by 10,865
Why Are There Still So Many Jobs? The History and Future of Workplace Automation
Autor, D. H. (2015) · Journal of Economic Perspectives · doi:10.1257/jep.29.3.3 · Cited by 3,917
Seventy-five trials and eleven systematic reviews a day: how will we ever keep up?
Bastian, H., Glasziou, P., & Chalmers, I. (2010) · PLoS Medicine · doi:10.1371/journal.pmed.1000326 · Cited by 1,188
How Quickly Do Systematic Reviews Go Out of Date? A Survival Analysis
Shojania, K. G., Sampson, M., Ansari, M. T., Ji, J., Doucette, S., & Moher, D. (2007) · Annals of Internal Medicine · doi:10.7326/0003-4819-147-4-200708210-00179 · Cited by 838
Acharya, A. S., Prakash, A., Saxena, P., & Nigam, A. (2013) · Indian Journal of Medical Specialities · doi:10.7713/ijms.2013.0032 · Cited by 692
Marshall, I. J., & Wallace, B. C. (2019) · Systematic Reviews · doi:10.1186/s13643-019-1074-9 · Cited by 638
Self-citationLiving Systematic Reviews: An Emerging Opportunity to Narrow the Evidence-Practice Gap
Elliott, J. H., Turner, T., Clavisi, O., Thomas, J., Higgins, J. P. T., Mavergames, C., & Gruen, R. L. (2014) · PLoS Medicine · doi:10.1371/journal.pmed.1001603 · Cited by 596
Self-citationLiving systematic reviews: 2. Combining human and machine effort
Thomas, J., Noel-Storr, A., Marshall, I., Wallace, B., McDonald, S., Mavergames, C., Glasziou, P., Shemilt, I., Synnot, A., Turner, T., et al. (2017) · Journal of Clinical Epidemiology · doi:10.1016/j.jclinepi.2017.08.011 · Cited by 355
Self-citationAutomating data extraction in systematic reviews: a systematic review
Jonnalagadda, S. R., Goyal, P., & Huffman, M. D. (2015) · Systematic Reviews · doi:10.1186/s13643-015-0066-7 · Cited by 287
The automation of systematic reviews
Tsafnat, G., Dunn, A., Glasziou, P., & Coiera, E. (2013) · BMJ · doi:10.1136/bmj.f139 · Cited by 131
Research works printed but not linked: 2
- Rogers. E.M. Simon and Schuster: Diffusion of innovations; 2010.
- Braun V, Clarke V, Terry G. Thematic analysis. Qual Res Clin Health Psychol. 2014;24:95–114.
Cited by
Artificial intelligence for literature reviews: opportunities and challenges
Bolaños, F., Salatino, A., Osborne, F., & Motta, E. (2024) · Artificial Intelligence Review · doi:10.1007/s10462-024-10902-3 · Cited by 246
“…as many of these software deviate from the guidelines set forth by SLR protocols and exhibit limited compatibility with other software systems [148, 149], iii) distrust , as there is uncertainty about the reliability and the mechanisms of these tools [150, 151], and iv) financial obstacles ,…”
Hamel, C., Hersi, M., Kelly, S. E., Tricco, A. C., Straus, S., Wells, G., Pham, B., & Hutton, B. (2021) · BMC Medical Research Methodology · doi:10.1186/s12874-021-01451-2 · Cited by 104
“Transparent and consistent reporting will help determine which title and abstract screening methods were applied when conducting the review, which will allow for replicability, and ultimately allow for conclusions to be made on best approaches and to address concerns of stakeholders [47].”
BackgroundScott, A. M., Forbes, C., Clark, J., Carter, M., Glasziou, P., & Munn, Z. (2021) · Journal of Clinical Epidemiology · doi:10.1016/j.jclinepi.2021.06.030 · Cited by 81
Jardim, P. S. J., Rose, C. J., Ames, H. M., Echavez, J. F. M., Van de Velde, S., & Muller, A. E. (2022) · BMC Medical Research Methodology · doi:10.1186/s12874-022-01649-y · Cited by 68
Muller, A. E., Ames, H. M. R., Jardim, P. S. J., & Rose, C. J. (2022) · Research Synthesis Methods · doi:10.1002/jrsm.1541 · Cited by 21
“13 This paper addresses the problem of categorizing studies based on study content, which has application in scoping reviews that aim to map the literature published on a particular topic, population, or context, and, in some cases, identify research questions for study in subsequent systematic…”
Background
Metadata
- Authors
- Arno, A., Elliott, J., Wallace, B., Turner, T., & Thomas, J.
- Affiliations
- University College London (GB)
- Monash University (AU)
- Northeastern University (US)
- Corresponding author
- Arno, Anneliese
- Venue
- Systematic Reviews
- Published
- 2021-01-08
- Volume
- 10
- Issue
- 1
- Pages
- 16-16
- ISSN
- 2046-4053 (ISSN-L)
- PMC
- PMC7796617
- OpenAlex
- W3120256265
- Semantic Scholar
- 66f88de8b5f0f6dbd8dcdf6a54c41d41f6296426
- Cited by
- 40
- References
- 16
- Citations by year
- 2026: 3 · 2025: 6 · 2024: 4 · 2023: 10 · 2022: 10 · 2021: 7
- FWCI
- 6.67
- Type
- journal article
- Language
- en
- Open access
- gold
- doi.org
- Licence
- cc-by
- creativecommons.org/licenses/by/4.0/ (tdm)
- creativecommons.org/licenses/by/4.0/ (vor)
- Locations
- Systematic Reviews (publishedVersion, cc-by)
- Research Square (acceptedVersion, cc-by)
- PubMed Central (publishedVersion, cc-by)
- PubMed (publishedVersion)
- DOAJ (DOAJ: Directory of Open Access Journals) (submittedVersion, cc-by-sa)
- UCL Discovery (University College London) (submittedVersion)
- Funders
- Joint UCL and Monash PhD Studentship
- Topics
- Health Sciences › Medicine › Public Health, Environmental and Occupational Health › Clinical practice guidelines implementation
- Social Sciences › Decision Sciences › Statistics, Probability and Uncertainty › Meta-analysis and systematic reviews
- Health Sciences › Medicine › Health Informatics › Artificial Intelligence in Healthcare and Education
- Keywords
- technology adoption, machine learning, compatibility, relative advantage, observability
- MeSH terms
- Systematic Reviews as Topic, Automation, Humans
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
The claim verdicts this report counts are experimental: their accuracy is not yet measured.
A language model drew the claims from the paper on 2026-10-05, under version 3 of the claim definition (model deepseek-v4.1-flash, prompt extract-v3).
A second model labelled each claim on 2026-10-05 (model jev-1.13-20260917, definition revision gold-guideline-v0.2).
Cited sources are checked with a language model’s help (qwen3.8-omni-flash).
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: The views of health guideline developers on the use of automation in health evidence synthesis. https://app.cochat.ai/papers/10.1186/s13643-020-01569-2
- The paper
- Arno, A., Elliott, J., Wallace, B., Turner, T., & Thomas, J. (2021). The views of health guideline developers on the use of automation in health evidence synthesis. Systematic Reviews. https://doi.org/10.1186/s13643-020-01569-2
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.

